Gene · 1408
Papers2,922
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,922
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Optogenetic Induction of Pyroptosis, Necroptosis, and Apoptosis in Mammalian Cell Lines. | Bio Protoc | 2023 | 37497455 | PubTator, text mining | PubMed |
| Influence of Chronotypes in Respiratory Pathology. | Open Respir Arch | 2023 | 37497245 | PubTator, text mining | PubMed |
| Circadian regulation in aging: Implications for spaceflight and life on earth. | Aging Cell | 2023 | 37493006 | PubTator, text mining | PubMed |
| Optogenetic modulation of guanine nucleotide exchange factors of Ras superfamily proteins directly controls cell shape and movement. | Front Cell Dev Biol | 2023 | 37492221 | PubTator, text mining | PubMed |
| A Review of Evidence for the Involvement of the Circadian Clock Genes into Malignant Transformation of Thyroid Tissue. | Clocks Sleep | 2023 | 37489438 | PubTator, text mining | PubMed |
| Disruption in the regulation of casein kinase 2 in circadian rhythm leads to pathological states: cancer, diabetes and neurodegenerative disorders. | Front Mol Neurosci | 2023 | 37475884 | PubTator, text mining | PubMed |
| Opto-RhoGEFs, an optimized optogenetic toolbox to reversibly control Rho GTPase activity on a global to subcellular scale, enabling precise control over vascular endothelial barrier strength. | Elife | 2023 | 37449837 | PubTator, text mining | PubMed |
| Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson's Disease. | Int J Mol Sci | 2023 | 37446264 | PubTator, text mining | PubMed |
| Molecular Biological Effects of Weak Low-Frequency Magnetic Fields: Frequency-Amplitude Efficiency Windows and Possible Mechanisms. | Int J Mol Sci | 2023 | 37446167 | PubTator, text mining | PubMed |
| Emotionally clocked out: cell-type specific regulation of mood and anxiety by the circadian clock system in the brain. | Front Mol Neurosci | 2023 | 37441675 | PubTator, text mining | PubMed |
| The circadian rhythm: an influential soundtrack in the diabetes story. | Front Endocrinol (Lausanne) | 2023 | 37441501 | PubTator, text mining | PubMed |
| CircZNF367 promotes osteoclast differentiation and osteoporosis by interacting with FUS to maintain CRY2 mRNA stability. | J Orthop Surg Res | 2023 | 37434265 | PubTator, text mining | PubMed |
| Sequence- and structure-specific RNA oligonucleotide binding attenuates heterogeneous nuclear ribonucleoprotein A1 dysfunction. | Front Mol Biosci | 2023 | 37426420 | PubTator, text mining | PubMed |
| Intelligent nanotherapeutic strategies for the delivery of CRISPR system. | Acta Pharm Sin B | 2023 | 37425051 | PubTator, text mining | PubMed |
| Light-responsive nanomedicine for cancer immunotherapy. | Acta Pharm Sin B | 2023 | 37425044 | PubTator, text mining | PubMed |
| Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer. | Front Mol Biosci | 2023 | 37409345 | PubTator, text mining | PubMed |
| Predictor of cognitive impairment: metabolic syndrome or circadian syndrome. | BMC Geriatr | 2023 | 37403015 | PubTator, text mining | PubMed |
| Optogenetic control of Wnt signaling models cell-intrinsic embryogenic patterning using 2D human pluripotent stem cell culture. | Development | 2023 | 37401411 | PubTator, text mining | PubMed |
| Differential expression of the circadian clock network correlates with tumour progression in gliomas. | BMC Med Genomics | 2023 | 37400829 | PubTator, text mining | PubMed |
| The role of circadian clocks in cancer: Mechanisms and clinical implications. | Genes Dis | 2023 | 37397565 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1408/papers?page=17